Curriculum Vitae Dr Pietro Sanpaolo - Il CROB

Barbieri V, Lapadula L, Castaldo G, Fusco V. Atti del XIX Congresso AIRO, Bologna 14-17 Novembre 2009,S22626) Rectal, Sigmoid and urinary bladder side effects in cervical cancer patients treated with 3D HDRintracavitary brachytherapy. Pedicini P, Clemente S, Califano G, Cozzolino M, caivano R, Chiumento C,Sanpaolo P, Barbieri V, Lapadula L, Castaldo G, Fusco V. Atti del XIX Congresso AIRO, Bologna 14-17Novembre 2009, S12627) Evaluation of factors affecting acute skin toxicity in adjuvant whole breast radiation therapy. V. Barbieri, P.Sanpaolo, D. Genovesi, P. Pedicini, V. Fusco, M. Aieta. Annals of Oncology 20 (Supplement 8), 200928) Factors affecting acute skin toxicity in adjuvant whole breast radiation therapy. V. Barbieri, P. Sanpaolo, D.Genovesi, M. Aieta, V. Fusco. Oncology 2009, 77 (Suppl 1): 13229) Anthracycline-based chemotherapy and left chest wall radiation therapy: transient electrocardiographicabnormalities and persistent perfusion findings. V. Barbieri, P. Sanpaolo, P. Pedicini, G. Gallucci, M.Coccaro, G. Storto, A. Nappi, M. Aieta, V. Fusco. Oncology 2009, 77 (Suppl 1): 13230) Interval time between surgery and adjuvant radiation therapy and local relapse in breast cancer: aretrospective study. P. Sanpaolo, V. Barbieri, D. Genovesi, P. Pedicini, V. Fusco. Annals of Oncology 21(Supplement 4), iv36-iv39, 201031) Modulated HER-2 expression by trastuzumab to obtain the best fractionation in breast cancer irradiation. P.Pedicini, G. Califano, R. Caivano, P. Sanpaolo, V. Barbieri, G. Castaldo, V. Fusco. Annals of Oncology 21(Supplement 4), iv36-iv39, 201032) Combined treatment of radiation and monoclonal antibody by modulated dose fractionation in head and neckcancer. P. Pedicini, G. Califano, R. Caivano, G. Castaldo, V. Barbieri, P. Sanpaolo , V. Fusco. Annals ofOncology 21 (Supplement 2), ii38, 201033) Modulated radiation dose fractionations of combined SIB-IMRT and monoclonal antibody treatment in headand neck cancer. P. Pedicini, M. Mazziotta, G. Castaldo, V. Barbieri, P. Sanpaolo, M. Aieta, V. Fusco.Oncology 2009, 77 (suppl 1), 15434) Esperienza monoistituzionale di radiochemioterapia neoadiuvante nel tumore del retto localmente avanzato V.Barbieri, P. Sanpaolo, L. Lapadula, P. Pedicini, G. Castaldo, C. Chiumento, A. Fiorentino, V. Fusco . Atti XXCongresso AIRO, Napoli 13-16 Novembre 201035) Frazionamenti di dose modulati nei trattamenti combinati di radiazione e anticorpo monoclonale nei tumoridel testa collo P. Pedicini, G. Califano, R. Caivano, A. Fiorentino, V. Barbieri, P. Sanpaolo, G. Castaldo, A.Morra, V. Ravo, P. Muto, V. Fusco, R. Orecchia. Atti XX Congresso AIRO, Napoli 13-16 Novembre 201036) Prognostic impact of triple negative phenotype in conservatively treated breast cancer. V. Barbieri, P.Sanpaolo, D. Genovesi. The Breast Journal, 2011; 17 (4): 377-38237) Interval between breast-conserving surgery and start of radiation therapy in early-stage breast cancer is notpredictive of local recurrence: a single-institution experience with a long waiting list. V. Barbieri, P.Sanpaolo, D. Genovesi. Clin Breast Cancer 2011, 11 (2), 114-2038) An observational study of cardiotoxicity after chemotherapy and radiotherapy in breast cancer. V. Fusco, G.Gallucci, M. Coccaro, L. Lapadula, V. Barbieri, P. Sanpaolo, A. Fiorentino, P.Pedicini, G. Storto, G. Castaldo.Radiother Oncol 2010; 96: S230